Keeps Biopharma킵스파마
256940 · KOSDAQ · ₩256940 · 킵스파마
₩5,510▲ ₩20 (0.36%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 23, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 16, 2026Open on DART
Predicted impact: Low
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (Idtrexed(CT900) 기반 항암 치료제의 제2상 임상시험계획(IND) 승인)Sep 11, 2026Open on DART
- Occurrence of Derivatives Trading Loss파생상품거래손실발생Aug 18, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 24, 2026Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jul 6, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 2, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 14, 2026Open on DART
- Change of Head Office Location본점소재지변경Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- [Amended] Notice of Reason for Concentrated Shareholders' Meeting Date[기재정정]주주총회집중일개최사유신고Mar 16, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 16, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 16, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 16, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 13, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 13, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 13, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 13, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (Idtrexed(CT900) 기반 항암 치료제의 제2상 임상시험계획 승인신청(IND))Mar 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 3, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (Idetrexed(CT900) 기반 항암 치료제 기술 도입 계약 체결)Feb 11, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 26, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Jan 19, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Merger Completion Report (Asset Acquisition and Transfer)합병등종료보고서(자산양수도)Oct 24, 2025Open on DART
- [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)[기재정정]주요사항보고서(유형자산양수결정)Oct 24, 2025Open on DART
- Major Matters Report (Decision on Acquisition of Tangible Assets)주요사항보고서(유형자산양수결정)Sep 2, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 23, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 10, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 17, 2025Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jun 17, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 16, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사May 30, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Merger Completion Report (Merger)합병등종료보고서(합병)Apr 10, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 9, 2025Open on DART
- Major Matters Report (Decision on Transfer of Equity Securities of Another Company)주요사항보고서(타법인주식및출자증권양도결정)Apr 9, 2025Open on DART
- Other management matters기타경영사항(자율공시) (제5회차 무기명식 무보증 사모 전환사채 재매각의 건)Mar 31, 2025Open on DART
- Notice of Company Name Change상호변경안내Mar 28, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 28, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Keeps Biopharma / 킵스파마 / 256940 / KRX:256940
Source: KRX statistical information